Juvenile Idiopathic Arthritis in Children in Estonia.
NCT01905319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2020-03-25
Summary
Aims of the study:
* to study the incidence rate of juvenile idiopathic arthritis (JIA) and it's clinical subtypes in Estonia for the years 1998-2000;
* to examine the course and short-term clinical outcome of JIA.
Method: a prospective population-based study carried on in 14 counties of Estonia
Conditions
- Epidemiology
Interventions
- OTHER
-
Blood collecting for storage of samples
Sponsors & Collaborators
-
University of Tartu
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-01-31
- Primary Completion
- 2000-12-31
- Completion
- 2002-12-31
More Related Trials
-
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT00962741 ·Status: COMPLETED ·Phase: PHASE3
-
Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
NCT02030613 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
NCT03780959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
NCT00195377 ·Status: COMPLETED
-
Juvenile Arthritis Quantitative Imaging
NCT02684695 ·Status: RECRUITING
-
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
NCT01287715 ·Status: UNKNOWN ·Phase: PHASE4
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment
NCT04407923 ·Status: UNKNOWN
-
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
NCT00004420 ·Status: COMPLETED ·Phase: NA
-
Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
NCT01145352 ·Status: COMPLETED
-
Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission
NCT06618937 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics
NCT03006991 ·Status: UNKNOWN
-
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
NCT00055055 ·Status: COMPLETED
-
Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin
NCT03466814 ·Status: COMPLETED
-
Treatment Tapering in JIA With Inactive Disease
NCT02840175 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
NCT03781375 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
NCT00652925 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
NCT02524340 ·Status: COMPLETED
-
Juvenile Rheumatoid Arthritis Research Registry
NCT00090571 ·Status: COMPLETED
-
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 ·Status: COMPLETED
-
Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
NCT02024334 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
NCT00078806 ·Status: TERMINATED ·Phase: PHASE3
-
Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
NCT01412021 ·Status: COMPLETED
-
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
NCT01399281 ·Status: UNKNOWN
-
Socio-economic Determinants for Acceptance and Choice of Biological Treatment
NCT04369651 ·Status: COMPLETED